# PDX Pharmaceuticals, Inc.: Form D filing

PDX Pharmaceuticals, Inc., a biotechnology company in Portland, OR, filed a Form D with the SEC in 2019. The latest, on November 27, 2019, reports $1.6 million sold of a $4 million offering to 2 investors.

Find out what PDX Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PDX%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PDX%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fpdx-pharmaceuticals-inc-1795304)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PDX%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PDX%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fpdx-pharmaceuticals-inc-1795304)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Oregon](https://specstream.ai/data/form-d/state/oregon): 434 rows, by operating companies, filed since November 1, 2024, $21.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/oregon
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3303 SW BOND AVENUE, CH13B, Portland, OR, 97239
- Phone: (503) 418-9306
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Oregon
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1795304

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 27, 2019 | New notice | $4,049,923 | $1,550,000 | $2,499,923 | 2 | Nov 18, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1795304/000179530419000002/0001795304-19-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Wassana Yantasee | Executive Officer, Director |  |
| Angela Hult | Director |  |
| Joe Gray | Director |  |
| Worapol Ngamcherdtrakul | Executive Officer |  |

## Other biotechnology companies in Oregon that filed recently

- [UBIVAC, INC.](https://specstream.ai/data/form-d/company/ubivac-inc-1713945) $80,000 · Aug 27, 2026
- [Trace Biosciences Inc.](https://specstream.ai/data/form-d/company/trace-biosciences-inc-2147501) $8.3 million · Aug 12, 2026

[Every Form D from the week of Nov 25, 2019](https://specstream.ai/data/form-d/week/2019-11-25) · [All recent filings in Oregon](https://specstream.ai/data/form-d/state/oregon) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what PDX Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).